Notify me when Frazier Life Sciences Management, L.P. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 47 | $3,337,397,700 | +$143,888,596 | -$129,941,579 | +$13,947,017 | MIRM, NAMS, VRNA, BBIO, ARQT | 13F-HR | 14 Nov 2025, 12:38 |
| Q2 2025 | 49 | $2,500,738,743 | +$287,280,463 | -$126,894,102 | +$160,386,361 | MIRM, VRNA, NAMS, BBIO, ARQT | 13F-HR | 14 Aug 2025, 11:53 |
| Q1 2025 | 47 | $2,187,908,599 | +$134,047,052 | -$224,689,480 | -$90,642,428 | NAMS, MIRM, VRNA, ARQT, BBIO | 13F-HR | 15 May 2025, 16:41 |
| Q4 2024 | 50 | $2,409,201,023 | +$143,683,231 | -$186,281,653 | -$42,598,422 | NAMS, MIRM, VRNA, KRYS, ARQT | 13F-HR | 14 Feb 2025, 18:44 |
| Q3 2024 | 53 | $2,495,000,226 | +$288,322,201 | -$85,112,061 | +$203,210,140 | MIRM, NAMS, PHAT, KRYS, MBX | 13F-HR | 15 Nov 2024, 07:41 |
| Q2 2024 | 49 | $2,137,654,638 | +$256,919,310 | -$322,414,972 | -$65,495,662 | NAMS, MIRM, KRYS, HLVX, PHAT | 13F-HR | 15 Aug 2024, 12:49 |
| Q1 2024 | 49 | $2,365,466,947 | +$229,858,739 | -$106,727,369 | +$123,131,370 | NAMS, KRYS, MIRM, HLVX, ALPN | 13F-HR | 15 May 2024, 12:00 |
| Q4 2023 | 49 | $1,870,349,025 | +$155,598,413 | -$83,826,699 | +$71,771,714 | MIRM, HLVX, NAMS, KRYS, BBIO | 13F-HR | 14 Feb 2024, 13:55 |
| Q3 2023 | 54 | $1,502,936,533 | +$238,208,243 | -$249,846,961 | -$11,638,718 | MIRM, HLVX, KRYS, NAMS, PHAT | 13F-HR | 14 Nov 2023, 13:40 |
| Q2 2023 | 53 | $1,674,511,029 | +$152,685,897 | -$80,120,064 | +$72,565,833 | HLVX, KDNY, PHAT, NAMS, KRYS | 13F-HR | 14 Aug 2023, 10:48 |
| Q1 2023 | 49 | $1,380,234,698 | +$108,540,935 | -$25,254,568 | +$83,286,367 | HLVX, NAMS, KDNY, ARQT, MIRM | 13F-HR | 15 May 2023, 12:41 |
| Q4 2022 | 44 | $1,607,998,686 | +$226,869,655 | -$11,010,665 | +$215,858,990 | HLVX, IMGO, ARQT, KDNY, NAMS | Restatement | 07 Feb 2023, 13:30 |
| Q3 2022 | 42 | $1,271,981,000 | +$201,483,667 | -$14,121,778 | +$187,361,889 | HLVX, ARQT, PHAT, KDNY, SNDX | 13F-HR | 14 Nov 2022, 09:29 |
| Q2 2022 | 41 | $1,059,640,000 | +$148,108,029 | -$143,595,009 | +$4,513,020 | ARQT, HLVX, KRYS, MIRM, KDNY | 13F-HR | 10 Aug 2022, 15:07 |
| Q1 2022 | 42 | $1,173,379,000 | $0 | ARQT, PHAT, MIRM, SRRA, KRYS | 13F-HR | 13 May 2022, 19:15 |